Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell

Claire Sanchez1, Darine El Hajj Diab, Vincent Connord

  • 1EA 4552, Université de Toulouse 3 , Toulouse, France.

ACS Nano
|January 10, 2014
PubMed

Insights

Targeted magnetic nanoparticles (MG-IONP-DY647) carrying cancer-targeting ligands show specific cell uptake and trigger cancer cell death via an alternating magnetic field, paving the way for novel nanotherapies.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Targeted magnetic nanoparticles offer a promising cancer nanotherapy approach.
  • Peptide conjugation impacts nanoparticle behavior and cellular interactions.
  • Understanding magnetic field-induced cell death mechanisms is crucial.

Purpose of the Study:

  • To design and characterize a novel nanoplatform (MG-IONP-DY647) for targeted cancer therapy.
  • To investigate the cellular uptake, trafficking, and specificity of MG-IONP-DY647.
  • To elucidate the mechanism of cell death induced by alternating magnetic fields in nanoparticle-loaded cancer cells.

Main Methods:

  • Synthesis and characterization of iron oxide nanocrystals grafted with CCK2R ligands (MG-IONP-DY647).
  • Assessment of inflammasome activation in macrophages.
  • Evaluation of cell recognition, internalization pathways (β-arrestin, clathrin, dynamin), and lysosomal trafficking in CCK2R-expressing cells.
  • Analysis of ligand density effects on binding and internalization.
  • Induction of apoptosis and cell death using alternating magnetic fields.

Main Results:

  • MG-IONP-DY647 demonstrated high specificity for CCK2R-expressing cells without stimulating inflammasome.
  • Internalization occurred via β-arrestin, clathrin-coated pits, and dynamin, with lysosomal trafficking.
  • Ligand density influenced binding and internalization rates.
  • Alternating magnetic field application induced apoptosis and cell death through a lysosomal pathway, even with low nanoparticle uptake.

Conclusions:

  • The designed nanoplatform (MG-IONP-DY647) is a specific and effective tool for targeting CCK2R-overexpressing cancer cells.
  • Nanoparticle-mediated magnetic hyperthermia can induce cancer cell death via lysosomal pathways.
  • These findings support the potential of ligand-grafted magnetic nanoparticles in cancer nanotherapy development.